Healthcare / Health Information ServicesSES
$1.37
+0.02 (+1.48%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $41.9M · quality 72.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
58/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.5B
P/E
10.5x
↓EV/EBITDA
4.6x
↓ROE
24.3%
↑Gross Margin
84.9%
↑Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+41.0%
FCF CAGR
+24.9%
FCF margin
32.7%
FCF / Net income
0.60x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $137.9M · net income $75.6M · FCF $45.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $137.9M | $137.9M | $108.0M | $72.0M | $49.2M |
| Net Income | $75.6M | $75.6M | $56.0M | $33.0M | $23.5M |
| EBITDA | $78.8M | $78.8M | $72.7M | $42.5M | $28.4M |
| EPS | 0.19 | 0.19 | 0.05 | 0.03 | 0.02 |
| Gross Margin | 84.9% | 84.9% | 83.9% | 78.8% | 75.5% |
| Operating Margin | 60.5% | 60.5% | 61.4% | 53.4% | 48.4% |
| Net Margin | 54.8% | 54.8% | 51.8% | 45.9% | 47.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.01 | 0.01 | -5.86 | 0.41 | 0.49 |
| Current Ratio | 13.22 | 13.22 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $45.1M | $45.1M | $41.9M | $8.5M | $23.1M |
| Returns | |||||
| ROE | 24.3% | 24.3% | -215.4% | 39.6% | 42.4% |
| Valuation | |||||
| P/E | 10.54 | 10.54 | — | — | — |
| EV/EBITDA | 4.57 | 4.57 | — | — | — |
| P/B | 1.72 | 1.72 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 27.7% | 27.7% | 50.0% | 46.4% | — |
| EPS Growth | 274.6% | 274.6% | 69.4% | 40.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-13.8%
EPS terminal req.
$0.12
Spread vs growth
288.4%
5Y implied EPS CAGR
-5.0%
EPS terminal req.
$0.15
Spread vs growth
279.6%
10Y implied EPS CAGR
2.2%
EPS terminal req.
$0.24
Spread vs growth
272.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-9.9%
Start / end P/E
30.0x → 7.2x
EPS bridge
0.05 → 0.19
Residual
-208.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.